Itau Unibanco Holding S.A.’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-422
Closed -$6.83K – 278
2023
Q4
$6.83K Sell
422
-129
-23% -$2.11K ﹤0.01% 330
2023
Q3
$6.78K Hold
551
– – ﹤0.01% 440
2023
Q2
$8.86K Buy
+551
New +$9.08K ﹤0.01% 471
2022
Q2
– Sell
-585
Closed -$7K – 568
2022
Q1
$7K Buy
585
+24
+4% +$505 ﹤0.01% 438
2021
Q4
$19K Buy
561
+139
+33% +$5.44K ﹤0.01% 369
2021
Q3
$20K Buy
422
+11
+3% +$509 ﹤0.01% 336
2021
Q2
$19K Buy
+411
New +$18.2K ﹤0.01% 301

Other funds holding NEO

Itau Unibanco Holding S.A.'s NEO Position: Q1 2024 in Review

Itau Unibanco Holding S.A. sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 422 shares — an estimated $6.83K sold.

Itau Unibanco Holding S.A. first reported a position in NEO in Q2 2021 and held it in 7 quarters. The position peaked at $20K in Q3 2021. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

  • Itau Unibanco Holding S.A. reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 422 NeoGenomics shares in Q1 2024, an estimated $6.83K.
  • Itau Unibanco Holding S.A. first reported a position in NeoGenomics in Q2 2021 and held it in 7 quarters.
  • Itau Unibanco Holding S.A.'s NeoGenomics position peaked at $20K in Q3 2021.
  • 263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2024, filed 14 May 2024.